Shopping Cart (0)
My Account

 Shopping Cart
Conferences | Training Courses | Market Reports | Managed Events | Past Conferences | Update Me
3 for 2 Offer SELECTBIO Conferences Circulating Biomarkers and Extracellular Vesicles Europe 2024Point-of-Care, Biosensors and Rapid Dx Europe 2024Organoids and Spheroids Europe 2024Lab-on-a-Chip and Microfluidics Europe 2024Emerging Technologies for Diagnostics & Liquid Biopsies - New Orleans 2024ePoster Award Prize
Home  \  Business Courses  \  Business Course Information
RegisterLogin

Business Courses

Cancer Biomarkers and Companion Diagnostics: Research, Collaborations, and Market Analysis


This Business Course is being held in Frankfurt, Germany on the 02 September 2013 at 17:00-20:00

Price:
Enal Razvi Image
Enal Razvi
Managing Director,
Select Biosciences Inc

This Business Course Presents a Technical and Market Analysis of the Cancer Biomarkers and Companion Diagnostics (CDx) Field Focusing on Technologies for Interrogating Cancer Biomarkers, Publications, Collaborations/Partnerships, and CDx/Rx Combinations Launched or in Development.

Specific Topics Presented in this Business Course:
  • Classes of Cancer Biomarkers
  • Number and Growth Rate of Publications Describing Putative Cancer Biomarkers
  • Validation of Cancer Biomarkers
  • Anatomic Pathology of Tumors and Assessment of Cancer Biomarkers Therein
  • The LDT vs. IVD Route to Platformizing and Commercialization of Biomarker Assays
  • Prognostic vs. Predictive Biomarkers and Comprehensive Listing
  • Adoption Curves of Various Biomarkers and Drivers Thereof
  • Companion Diagnostics (CDx) Development: Research Trends
  • CDx: Up-to-date Listing of Collaborations and Partnerships
  • CDx/Rx Combinations
  • Market Opportunities for Stakeholders in the CDx Space

All Delegates of this Business Course Receive Electronic Files of Materials on CD with Full Commercial Rights for Use in Business Planning Presentations, R&D, and Corporate Presentations.

Who Should Attend:

  • Academic Researchers Involved in Discovery or Validation of Biomarkers
  • Industry Researchers
  • Business Development and Licensing Professionals

For More Details on the Content of this Business Course, please e-mail: enal@selectbio.us